Loading chart…
WEEKEND
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients.
Torrent Pharmaceuticals Limited (TORNTPHARM) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The TORNTPHARM share price is ₹4,773.00 (+1.34% today), with a market capitalisation of ₹1.82T and a price-to-earnings (P/E) ratio of 80.6. MarketRipple tracks the TORNTPHARM investment thesis, the ripple-chain impact of market events on Torrent Pharmaceuticals Limited, and the Healthcare sector outlook.
Open
₹4,784.00
High
₹4,800.00
Low
₹4,750.10
Prev. Close
₹4,710.00
52W High
₹5,250.00
52W Low
₹3,602.00
Day range
₹4,750.10–₹4,800.00
52-week range
₹3,602.00–₹5,250.00
Volume
13K
P/E
80.6
ROE
15.7%
D/E
1.79
Margin
12.2%
Torrent Pharmaceuticals Limited (NSE: TORNTPHARM) is currently trading at ₹4,773.00 (+1.34%).
Torrent Pharmaceuticals Limited's market capitalization is ₹1.82T.
Torrent Pharmaceuticals Limited's price-to-earnings (P/E) ratio is 80.6.
Torrent Pharmaceuticals Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Torrent Pharmaceuticals Limited currently reads positive, based on 28 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.